These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3175798)

  • 1. [Local peptichemio prophylaxis in surface tumors of the bladder (Ta-T1 stage)].
    Croce L; Palladini PD; Brausi M; Gavioli M; Latini A
    Minerva Urol Nefrol; 1988; 40(2):85-8. PubMed ID: 3175798
    [No Abstract]   [Full Text] [Related]  

  • 2. On the local treatment of urinary bladder tumours with peptichemio.
    Battelli T; Bonsignori M; Manocchi P; Perilli A; Lombardi R
    Panminerva Med; 1975; 17(7-8):262-4. PubMed ID: 1161332
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of stage Ta,T1 and Tis bladder tumors using Calmette-Guérin bacillus vaccine].
    Bretheau D; Lechevallier E; Rossi D; Albert P; de Fromont M; Coulange C
    Prog Urol; 1993; 3(4):608-17. PubMed ID: 8401621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptichemio in advanced breast cancer: a clinical evaluation in 32 patients.
    Fornasiero A; Daniele O; Fosser VP; Paccagnella A; Salvagno L; Sileni VC; Morandi P; Fiorentino MV
    Cancer Treat Rep; 1986 May; 70(5):647-9. PubMed ID: 3708613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of Peptichemio in neoplasms of the urogenital system].
    Aliffi E; De Grande G
    Minerva Urol; 1976 SEP-OCT; 28(5):247-52. PubMed ID: 1004464
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prophylaxis of superficial tumors of the bladder with interferon alfa-2B].
    Maffucci A; Fico A; Giannella L; Giannella R
    Arch Monaldi Mal Torace; 1990; 45(6):415-8. PubMed ID: 2152750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of M-component changes and plasma cell labeling index in 25 patients with multiple myeloma treated with peptichemio.
    Riccardi A; Montecucco C; Danova M; Ucci G; Merlini G; Ascari E
    Cancer Treat Rep; 1985 Sep; 69(9):971-5. PubMed ID: 4028038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of non invasive bladder cancers. T1Ga urothelial cell carcinoma: benefit of immediate post operative instillation?].
    Rouprêt M; Guillotreau J; Irani J; Zerbib M
    Prog Urol; 2010 Mar; 20 Suppl 1():S46-9. PubMed ID: 20493444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peptichemio treatment of a patient with terminal stage myeloma].
    Goldschmidt E; Menkes CJ; Job-Deslandre C
    Presse Med; 1984 Dec; 13(45):2766. PubMed ID: 6240055
    [No Abstract]   [Full Text] [Related]  

  • 11. Peptichemio in multiple myeloma. (Preliminary results).
    Cavo M; Gobbi M; Tura S
    Haematologica; 1981 Apr; 66(2):208-15. PubMed ID: 6791997
    [No Abstract]   [Full Text] [Related]  

  • 12. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peptichemio treatment of myeloma. Study of 6 cases].
    Job-Deslandre C; Menkes CJ
    Presse Med; 1986 Mar; 15(13):619. PubMed ID: 2939422
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K; Chihara Y; Kondo H; Hirao Y
    Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative activity, response to therapy and survival in multiple myeloma.
    Riccardi A; Montecucco C; Merlini G; Ucci G; Cremonini N; Gobbi PG; Ascari E
    Haematologica; 1984; 69(2):148-62. PubMed ID: 6429002
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of neoplasia of the bladder with topical application of a synthetic peptide complex preparation: preliminary results.
    Battelli T; Bonsignori M; Lombardi R; Manocchi P; Perilli A
    Curr Med Res Opin; 1976; 4(3):189-1. PubMed ID: 949898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancer.
    Yap HY; Blumenschein GR; Hortobagyi GN; Buzdar AU; Schell FC; Bodey GP
    Am J Clin Oncol; 1982 Oct; 5(5):511-4. PubMed ID: 7180829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of Clinical, Histopathological and Follow-Up Data on Transurethral Resections of the Bladder Performed during One Year at a University Centre].
    Otto W; Fritsche HM; Dirmeyer M; Burger M; Straub M; Rössler W; Wieland WF; Denzinger S
    Aktuelle Urol; 2010 Sep; 41(5):316-9. PubMed ID: 20669097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.